PRIA Logo™
LouisianaSB 2432025 Regular SessionSenateWALLET

TAX EXEMPTIONS: Provides relative to the sales and use tax exemption for the sale of certain prescription drugs. (gov sig) (EN SEE FISC NOTE LF RV See Note)

Sponsored By: Mike Reese (Republican)

Signed by Governor

Ways and MeansRevenue and Fiscal Affairs

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Medicaid and CHIP prescription tax exemption clarified

Prescription drugs bought for Louisiana Medicaid or Louisiana Children’s Health Insurance Program enrollees are exempt from state and local sales and use taxes. This exemption does not cover non-prescription items or purchases for people outside those programs. The law clarifies the existing exemption; it does not create new rights or duties. It takes effect upon the governor’s signature, under constitutional timing without signature, or the day after a legislative veto override.

Sponsors & Cosponsors

Sponsor

  • Mike Reese

    Republican • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 140 • No: 0

House vote • 6/3/2025

Read third time by title, roll called on final passage, yeas 95, nays 0. Finally passed, ordered to the Senate.

Yes: 95 • No: 0

House vote • 5/27/2025

Reported favorably

Yes: 14 • No: 0

Senate vote • 5/8/2025

Read by title, passed by a vote of 31 yeas and 0 nays, and sent to the House. Motion to reconsider tabled.

Yes: 31 • No: 0

Actions Timeline

  1. Signed by the Governor. Becomes Act No. 339.

    6/11/2025Senate

  2. Effective date 6/11/2025.

    6/11/2025Senate

  3. Sent to the Governor by the Secretary of the Senate.

    6/9/2025Senate

  4. Received from the House without amendments.

    6/8/2025Senate

  5. Enrolled. Signed by the President of the Senate.

    6/8/2025Senate

  6. Signed by the Speaker of the House.

    6/8/2025House

  7. Read third time by title, roll called on final passage, yeas 95, nays 0. Finally passed, ordered to the Senate.

    6/3/2025House

  8. Scheduled for floor debate on 06/03/2025.

    6/2/2025House

  9. Read by title, passed to 3rd reading.

    5/29/2025House

  10. Reported without Legislative Bureau amendments.

    5/28/2025House

  11. Reported favorably (14-0). Referred to the Legislative Bureau.

    5/27/2025House

  12. Read by title, under the rules, referred to the Committee on Ways and Means.

    5/13/2025House

  13. Received in the House from the Senate, read by title, lies over under the rules.

    5/12/2025House

  14. Read by title, passed by a vote of 31 yeas and 0 nays, and sent to the House. Motion to reconsider tabled.

    5/8/2025Senate

  15. Read by title. Committee amendments read and adopted. Ordered engrossed and passed to third reading and final passage.

    5/7/2025Senate

  16. Reported with amendments.

    5/6/2025Senate

  17. Read second time by title and referred to the Committee on Revenue and Fiscal Affairs.

    4/28/2025Senate

  18. Introduced in the Senate. Read by title and placed on the Calendar for a second reading.

    4/23/2025Senate

Bill Text

Related Bills

Back to State Legislation